Protein Description

Gene Symbol MIF
Entrez ID 4282
Uniprot ID P14174
Descriptionmacrophage migration inhibitory factor (glycosylation-inhibiting factor)
Chromosomal Locationchr22: 23,894,004-23,895,227
OntologyGO IDGO TermDefinitionEvidence

BP

GO:0001516

prostaglandin biosynthetic process

The chemical reactions and pathways resulting in the formation of prostaglandins, any of a group of biologically active metabolites which contain a cyclopentane ring.

IDA

BP

GO:0002906

negative regulation of mature B cell apoptotic process

Any process that stops, prevents, or reduces the frequency, rate, or extent of mature B cell apoptotic process.

IEA

BP

GO:0006954

inflammatory response

The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.

IEA

BP

GO:0007166

cell surface receptor signaling pathway

A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.

IDA

BP

GO:0007569

cell aging

An aging process that has as participant a cell after a cell has stopped dividing. Cell aging may occur when a cell has temporarily stopped dividing through cell cycle arrest (GO:0007050) or when a cell has permanently stopped dividing, in which case it is undergoing cellular senescence (GO:0090398). May precede cell death (GO:0008219) and succeed cell maturation (GO:0048469).

IEA

BP

GO:0008283

cell proliferation

The multiplication or reproduction of cells, resulting in the expansion of a cell population.

IDA

BP

GO:0010629

negative regulation of gene expression

Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.

IDA

BP

GO:0010739

positive regulation of protein kinase A signaling

Any process that increases the rate, frequency, or extent of protein kinase A signaling. PKA signaling is the series of reactions, mediated by the intracellular serine/threonine kinase protein kinase A, which occurs as a result of a single trigger reaction or compound.

IDA

BP

GO:0019752

carboxylic acid metabolic process

The chemical reactions and pathways involving carboxylic acids, any organic acid containing one or more carboxyl (COOH) groups or anions (COO-).

IDA

BP

GO:0030330

DNA damage response, signal transduction by p53 class mediator

A cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage.

IEA

BP

GO:0030890

positive regulation of B cell proliferation

Any process that activates or increases the rate or extent of B cell proliferation.

IDA

BP

GO:0031666

positive regulation of lipopolysaccharide-mediated signaling pathway

Any process that activates or increases the frequency, rate or extent of signaling in response to detection of lipopolysaccharide.

IEA

BP

GO:0032269

negative regulation of cellular protein metabolic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell.

IEA

BP

GO:0033033

negative regulation of myeloid cell apoptotic process

Any process that stops, prevents, or reduces the frequency, rate, or extent of a myeloid cell apoptotic process.

IEA

BP

GO:0033138

positive regulation of peptidyl-serine phosphorylation

Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.

IDA

BP

GO:0042327

positive regulation of phosphorylation

Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule.

IDA

BP

GO:0043030

regulation of macrophage activation

Any process that modulates the frequency or rate of macrophage activation.

NAS

BP

GO:0043066

negative regulation of apoptotic process

Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.

IDA

BP

GO:0043406

positive regulation of MAP kinase activity

Any process that activates or increases the frequency, rate or extent of MAP kinase activity.

IEA

BP

GO:0043518

negative regulation of DNA damage response, signal transduction by p53 class mediator

Any process that stops, prevents, or reduces the frequency, rate or extent of the cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage.

IDA

BP

GO:0045087

innate immune response

Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.

IEA

BP

GO:0048146

positive regulation of fibroblast proliferation

Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.

IDA

BP

GO:0050715

positive regulation of cytokine secretion

Any process that activates or increases the frequency, rate or extent of the regulated release of cytokines from a cell.

IDA

BP

GO:0050731

positive regulation of peptidyl-tyrosine phosphorylation

Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.

IDA

BP

GO:0050900

leukocyte migration

The movement of a leukocyte within or between different tissues and organs of the body.

TAS

BP

GO:0050918

positive chemotaxis

The directed movement of a motile cell or organism towards a higher concentration of a chemical.

IEA

BP

GO:0061078

positive regulation of prostaglandin secretion involved in immune response

Any process that activates or increases the frequency, rate or extent of the regulated release of a prostaglandin from a cell and contributes to the immune response.

IEA

BP

GO:0061081

positive regulation of myeloid leukocyte cytokine production involved in immune response

Any process that modulates the rate, frequency, or extent of the production of a cytokine that contributes to the immune response.

IEA

BP

GO:0070207

protein homotrimerization

The formation of a protein homotrimer, a macromolecular structure consisting of three noncovalently associated identical subunits.

IPI

BP

GO:0070374

positive regulation of ERK1 and ERK2 cascade

Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.

IDA

BP

GO:0071157

negative regulation of cell cycle arrest

Any process that decreases the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases.

IDA

BP

GO:0090238

positive regulation of arachidonic acid secretion

Any process that increases the rate, frequency, or extent of arachidonic acid secretion, the controlled release of arachidonic acid from a cell or a tissue.

IEA

BP

GO:0090344

negative regulation of cell aging

Any process that decreases the rate, frequency, or extent of cell aging. Cell aging is the progression of the cell from its inception to the end of its lifespan.

IDA

BP

GO:1902166

negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator

Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator.

IDA

BP

GO:2000343

positive regulation of chemokine (C-X-C motif) ligand 2 production

Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.

IEA

CC

GO:0005576

extracellular region

The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.

IDA|TAS

CC

GO:0005615

extracellular space

That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.

IEA

CC

GO:0005654

nucleoplasm

That part of the nuclear content other than the chromosomes or the nucleolus.

IDA

CC

GO:0005737

cytoplasm

All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

IDA

CC

GO:0009986

cell surface

The external part of the cell wall and/or plasma membrane.

IDA

CC

GO:0031982

vesicle

Any small, fluid-filled, spherical organelle enclosed by membrane.

IDA

CC

GO:0043209

myelin sheath

An electrically insulating fatty layer that surrounds the axons of many neurons. It is an outgrowth of glial cells: Schwann cells supply the myelin for peripheral neurons while oligodendrocytes supply it to those of the central nervous system.

IEA

CC

GO:0070062

extracellular exosome

A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.

IDA

MF

GO:0004167

dopachrome isomerase activity

Catalysis of the reaction: L-dopachrome = 5,6-dihydroxyindole-2-carboxylate.

IDA

MF

GO:0005102

receptor binding

Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

IPI

MF

GO:0005125

cytokine activity

Functions to control the survival, growth, differentiation and effector function of tissues and cells.

IDA

MF

GO:0005126

cytokine receptor binding

Interacting selectively and non-covalently with a cytokine receptor.

IPI

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0042056

chemoattractant activity

Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.

IDA

MF

GO:0050178

phenylpyruvate tautomerase activity

Catalysis of the reaction: keto-phenylpyruvate = enol-phenylpyruvate.

IDA

Domain IDDescription

IPR001398

Macrophage migration inhibitory factor

IPR014347

Tautomerase/MIF superfamily

IPR019829

Macrophage migration inhibitory factor, conserved site

Pathway IDPathway TermPathway Source

hsa00350

Tyrosine metabolism

KEGG

hsa00360

Phenylalanine metabolism

KEGG

WP2431

Spinal Cord Injury

WikiPathways

WP236

Adipogenesis

WikiPathways

UMLS CUIUMLS Term

C0003469

Anxiety Disorders

C0003873

Rheumatoid Arthritis

C0004352

Autistic Disorder

C0009319

Colitis

C0011581

Depressive Disorder

C0021368

Inflammation

C0022548

Keloid

C0024667

Animal Mammary Neoplasms

C0024668

Mammary Neoplasms, Experimental

C0025261

Memory Disorders

C0033578

Prostatic Neoplasms

C0038325

Stevens-Johnson Syndrome

C0243026

Sepsis

C1458155

Mammary Neoplasms

TissueCell Type

breast

glandular cells

endometrium

glandular cells

kidney

cells in tubules

prostate

glandular cells

Database Name

DisGeNET

DGA

Pubmed IDAuthorYearTitle

22951915

Haozi et al.

2012

Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome

23824412

Piltonen et al.

2013

Mesenchymal Stem/Progenitors and Other Endometrial Cell Types From Women With Polycystic Ovary Syndrome (PCOS) Display Inflammatory and Oncogenic Potential

Gene SymbolEntrez IDUniprot IDScore

VCL

7414

P18206

0.49

UFM1

51569

P61960

0.49

HSP90AA1

3320

P07900

0.63

STUB1

10273

Q9UNE7

0.63

STRN4

29888

Q9NRL3

0.63

WDYHV1

55093

Q96HA8

0.63

TP53

7157

P04637

0.65

NME1

4830

P15531

0.7

GORASP2

26003

Q9H8Y8

0.73

CD74

972

P04233

0.79

MIF

4282

P14174

0.83

ANXA11

311

P50995

0.49

CAPG

822

P40121

0.49

CLNS1A

1207

P54105

0.49

CRIP1

1396

P50238

0.49

AKR1C2

1646

P52895

0.49

ENO1

2023

P06733

0.49

GBE1

2632

Q04446

0.49

HINT1

3094

P49773

0.49

IGBP1

3476

P78318

0.49

LDHA

3939

P00338

0.49

LDHB

3945

P07195

0.49

MPI

4351

P34949

0.49

PCBP1

5093

Q15365

0.49

PCMT1

5110

P22061

0.49

FSCN1

6624

Q16658

0.49

SPR

6697

P35270

0.49

TKT

7086

P29401

0.49

PIR

8544

O00625

0.49

PDCD6IP

10015

Q8WUM4

0.49

PDCD6

10016

O75340

0.49

COX17

10063

Q14061

0.49

PAICS

10606

P22234

0.49

YKT6

10652

O15498

0.49

DSTN

11034

P60981

0.49

PARK7

11315

Q99497

0.49

TIMM13

26517

Q9Y5L4

0.49

PABPC1

26986

P11940

0.49

LAP3

51056

P28838

0.49

CEP290

80184

O15078

0.49

NANP

140838

Q8TBE9

0.49

CDK2

1017

P24941

0.63

EPB41

2035

P11171

0.63

FN1

2335

P02751

0.63

HLA-B

3106

P30480

0.63

ILK

3611

Q13418

0.63

ITGA4

3676

P13612

0.63

MCM2

4171

P49736

0.63

MDM2

4193

Q00987

0.63

MPG

4350

P29372

0.63

PRKAB1

5564

Q9Y478

0.63

TRAF6

7189

Q9Y4K3

0.63

TNFRSF14

8764

Q92956

0.63

TNFRSF10D

8793

Q9UBN6

0.63

CFLAR

8837

O15519

0.63

ATG5

9474

Q9H1Y0

0.63

IKBKE

9641

Q14164

0.63

CUL7

9820

Q14999

0.63

EIF1B

10289

O60739

0.63

GABARAP

11337

O95166

0.63

GABARAPL2

11345

P60520

0.63

GABARAPL1

23710

Q9H0R8

0.63

FTSJ1

24140

Q9UET6

0.63

DSTYK

25778

Q6XUX3

0.63

UPF2

26019

Q9HAU5

0.63

BEX3

27018

Q00994

0.63

PINX1

54984

Q96BK5

0.63

FBXO11

80204

Q86XK2

0.63

MAP1LC3B

81631

Q9GZQ8

0.63

MAP1LC3A

84557

Q9H492

0.63

ASB15

142685

Q8WXK1

0.63

COPS6

10980

Q7L5N1

0.65

MKNK2

2872

Q9HBH9

0.72

VPS26A

9559

O75436

0.72

ZNF408

79797

Q9H9D4

0.73

BCL2L11

10018

O43521

0.75

FIBP

9158

O43427

0.76

VCAM1

7412

P19320

0.82

VHL

7428

P40337

0.82

BNIPL

149428

Q7Z465

0.89

COPS5

10987

Q92905

0.9